CAS 6809-52-5
:Teprenone
- (5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
- 5,9,13,17-Nonadecatetraen-2-one, 6,10,14,18-tetramethyl-
- 6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one
- 6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one, mixture of (5E,9E,13E) and (5Z,9E,13E) isomers
- E 0671
- E 36U31
- Geranylgeranylacetone
- Selbex
- Teprenona
- Teprenona [INN-Spanish]
- Teprenonum
- Teprenonum [INN-Latin]
- Unii-S8S8451A4O
- Teprenone
- Teprenone
- Tetraprenylacetone
- 6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetren-2-one
- See more synonyms
Teprenone [mixture of (5E,9E,13E)- and (5Z,9E,13E)- isomers]
CAS:Formula:C23H38OPurity:>95.0%(GC)Color and Shape:Colorless to Light yellow to Light orange clear liquidMolecular weight:330.56Teprenone
CAS:Teprenone (Geranylgeranylacetone) is a anti-ulcer drug, and works as an inducer of heat shock proteins (HSPs).Formula:C23H38OPurity:99.1% - 99.96%Color and Shape:SolidMolecular weight:330.55Teprenone
CAS:Controlled ProductApplications An anti-ulcerative. Geranylgeranylacetone can induce expression of HSP70, HSPB8, and HSPB1. Induction of HSP70 expression is protective against the development of various diseases, such as inflammatory bowel disease, hypoxic/ischemic brain injury and spinal and bulbar muscular atrophy (cytoprotective and anti-inflammatory effects). Reports indicate that GGA protects against NSAID-induced gastric and intestinal lesions by induction of HSP70 expression. Other studies have shown that GGA induces expression of HSPB8 and HSPB1 and reduces the formation of amyloid oligomers as well as insoluble aggregates in HSPB5 R120G TG mice.
References Murakami, M., et al.: Arzneim.-Forsch., 31, 799 (1981), Nishizawa, Y., et al.: Xenobiotica, 17, 575 (1987),Formula:C23H38OColor and Shape:NeatMolecular weight:330.55








